Brian Daniels
Corporate Officer/Principal chez APEXIGEN, INC.
Profil
Brian Daniels, M.D.
joined 5AM Ventures as a Venture Partner in 2014 and transitioned to Partner in 2018.
Dr. Daniels previously spent over two decades in clinical drug development, including leading the Development and Medical Affairs at Bristol-Myers Squibb for the last ten years.
He directed the development of numerous innovative medicines that have contributed to the improvement for patients across a range of serious diseases.
These include: ORENCIA and NULOJIX in immunology/transplant, REYATAZ, DAKLINZA and BARACLUDE in virology, ONGLYZA, FARXIGA and MYALEPT in metabolics, ELIQUIS in CV and YERVOY, OPDIVO, SPRYCEL and IXEMPRA in oncology.
Dr. Daniels is currently a board director for Artiva Biotherapeutics and Inipharm and was previously on the board of Cabaletta Bio (NASDAQ: CABA).
He is on the Scientific Advisory Boards for Soteria and Ideaya Biosciences (NASDAQ: IDYA).
Dr. Daniels received B.S.
and M.S.
degrees from MIT and his M.D.
from Washington University in St. Louis.
He trained in internal medicine at New York Hospital and Rheumatology/Immunology at UCSF.
Dr. Daniels is based in the San Francisco, CA office.
Postes actifs de Brian Daniels
Sociétés | Poste | Début |
---|---|---|
APEXIGEN, INC. | Corporate Officer/Principal | - |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Chairman | 01/06/2020 |
Inipharm, Inc.
Inipharm, Inc. Pharmaceuticals: MajorHealth Technology Inipharm, Inc. provides health care services. The company was founded by Brian Farmer and Mike Gallatin in 2018 and is headquartered in Bellevue, WA. | Director/Board Member | 11/11/2020 |
RareCyte, Inc.
RareCyte, Inc. Medical SpecialtiesHealth Technology RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA. | Director/Board Member | - |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Private Equity Investor | 14/11/2014 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Director/Board Member | - |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Director/Board Member | 13/05/2011 |
Anciens postes connus de Brian Daniels
Sociétés | Poste | Fin |
---|---|---|
CABALETTA BIO, INC. | Director/Board Member | 24/06/2021 |
NOVO NORDISK A/S | Director/Board Member | 01/03/2021 |
░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Brian Daniels
Massachusetts Institute of Technology | Graduate Degree |
Washington University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 5 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
NOVO NORDISK A/S | Health Technology |
IDEAYA BIOSCIENCES, INC. | Health Technology |
CABALETTA BIO, INC. | Health Technology |
APEXIGEN, INC. | Health Technology |
Entreprise privées | 13 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Spyryx Biosciences, Inc.
Spyryx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Spyryx Biosciences, Inc. develops therapeutics for obstructive lung diseases with a particular focus on Cystic Fibrosis and chronic obstructive pulmonary disease. The company was founded by Robert Tarran in 2013 and is headquartered in Durham, NC. | Health Technology |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Finance |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Novo Nordisk Ltd.
Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Health Services |
Armaron Bio Ltd.
Armaron Bio Ltd. Electronic Equipment/InstrumentsElectronic Technology Armaron Bio Ltd. operates a clinical stage biotechnology firm. It discovers, develops, and commercializes proprietary molecules to prevent heart failure, diabetes, and other serious diseases. The company is headquartered in Melbourne, Australia. | Electronic Technology |
RareCyte, Inc.
RareCyte, Inc. Medical SpecialtiesHealth Technology RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA. | Health Technology |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
Nohla Therapeutics, Inc.
Nohla Therapeutics, Inc. BiotechnologyHealth Technology Nohla Therapeutics, Inc. developed cellular therapies for hematological disorders. The firm's products used without the need for HLA matching and promote hematopoietic recovery in patients at risk for neutropenia after intensive chemotherapy and/or radiation treatment for critical diseases. The company was founded by Colleen Delaney and was headquartered in Seattle, WA. | Health Technology |
The Boston Consulting Group | |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
Inipharm, Inc.
Inipharm, Inc. Pharmaceuticals: MajorHealth Technology Inipharm, Inc. provides health care services. The company was founded by Brian Farmer and Mike Gallatin in 2018 and is headquartered in Bellevue, WA. | Health Technology |